Api Group Corp (APG)vsVertex Pharmaceuticals Inc (VRTX)
APG
Api Group Corp
$44.67
-2.76%
INDUSTRIALS · Cap: $19.87B
VRTX
Vertex Pharmaceuticals Inc
$427.65
+0.78%
HEALTHCARE · Cap: $108.71B
Smart Verdict
WallStSmart Research — data-driven comparison
Vertex Pharmaceuticals Inc generates 47% more annual revenue ($12.00B vs $8.17B). VRTX leads profitability with a 32.9% profit margin vs 4.0%. VRTX earns a higher WallStSmart Score of 66/100 (B-).
APG
Hold49
out of 100
Grade: D+
VRTX
Strong Buy66
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-23.3%
Fair Value
$36.50
Current Price
$44.67
$8.17 premium
Margin of Safety
+56.0%
Fair Value
$973.13
Current Price
$427.65
$545.48 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 61.4% YoY
15.3% revenue growth
Keeps 33 of every $100 in revenue as profit
Strong operational efficiency at 39.6%
Safe zone — low bankruptcy risk
Large-cap with strong market position
Every $100 of equity generates 23 in profit
Conservative balance sheet, low leverage
Areas to Watch
Distress zone — elevated risk
4.0% margin — thin
Expensive relative to growth rate
Moderate valuation
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : APG
The strongest argument for APG centers on EPS Growth, Revenue Growth. Revenue growth of 15.3% demonstrates continued momentum.
Bull Case : VRTX
The strongest argument for VRTX centers on Profit Margin, Operating Margin, Altman Z-Score. Profitability is solid with margins at 32.9% and operating margin at 39.6%.
Bear Case : APG
The primary concerns for APG are Altman Z-Score, Profit Margin. Thin 4.0% margins leave little buffer for downturns.
Bear Case : VRTX
The primary concerns for VRTX are PEG Ratio, P/E Ratio, Piotroski F-Score.
Key Dynamics to Monitor
APG profiles as a growth stock while VRTX is a mature play — different risk/reward profiles.
APG carries more volatility with a beta of 1.69 — expect wider price swings.
APG is growing revenue faster at 15.3% — sustainability is the question.
VRTX generates stronger free cash flow (349M), providing more financial flexibility.
Bottom Line
VRTX scores higher overall (66/100 vs 49/100), backed by strong 32.9% margins. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Api Group Corp
INDUSTRIALS · ENGINEERING & CONSTRUCTION · USA
APi Group Corporation provides security, specialty and industrial services primarily in North America. The company is headquartered in New Brighton, Minnesota.
Visit Website →Vertex Pharmaceuticals Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
Compare with Other ENGINEERING & CONSTRUCTION Stocks
Want to dig deeper into these stocks?